Taco Bell is testing a meat alternative dubbed the Cravetarian Taco that includes a boldly seasoned protein made from peas and chickpeas.
The taco chain is also set to launch new offerings featuring Beyond Meat.
The Cravetarian Taco has a crunchy corn shell that houses cheddar cheese, diced tomatoes, lettuce, and reduced-fat sour cream.
It's only available at Taco Bell's Orange County, California, location until April 29 for $2.19.
The new vegan meat alternative was created at the Taco Bell Test Kitchen.
The term Cravetarian, according to Taco Bell, emphasizes that bold flavors need not be sacrificed for their lifestyle."
The chain is popular with vegetarians because it offers to substitute black beans for meat.
According to Taco Bell, fans who are meat-eaters, vegetarians, and veggie-curious will find their next plant-based obsession.
The company is also developing other plant-based meats with Beyond Meat and will test them later this year.


Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 



